Related Experiment Video
Updated: Jul 6, 2025

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
Published on: September 10, 2021
Gastrointestinal Manifestations Are Associated with Severe COVID-19 in Children
Esra Betul Akkoyun1, Bilal Ashraf2, Natasha Hanners1
1Division of Pediatric Infectious Disease, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Insights
Gastrointestinal symptoms like abdominal pain may indicate severe COVID-19 in children. Early identification of these pediatric cases is crucial for better outcomes.
Area of Science:
- Pediatric infectious diseases
- Viral respiratory illnesses
- Gastroenterology
Background:
- Children can develop a spectrum of COVID-19 symptoms, ranging from mild to severe.
- Pre-existing medical conditions can exacerbate COVID-19 severity in pediatric patients.
Purpose of the Study:
- To identify factors associated with severe COVID-19 in children.
- To compare characteristics of hospitalized versus non-hospitalized pediatric COVID-19 cases.
- To differentiate outcomes for pediatric COVID-19 patients admitted to the intensive care unit (ICU) versus those on the general floor.
Main Methods:
- A single-center case-control study involving 253 pediatric patients diagnosed with COVID-19.
- Categorization of patients based on hospitalization status (hospital vs. non-hospital).
- Assessment of intensive care unit (ICU) admission (ICU vs. floor).
Main Results:
- 36% of pediatric COVID-19 patients had at least one underlying medical condition, most commonly pulmonary disorders (e.g., asthma).
- Hospitalized children were more likely to have comorbidities like obstructive sleep apnea (OSA) and neurodevelopmental disorders.
- Gastrointestinal symptoms (abdominal pain) and respiratory symptoms (shortness of breath, diarrhea) were more frequent in severe cases and ICU admissions.
Conclusions:
- Early identification of severe pediatric COVID-19 is vital for improving patient outcomes.
- Gastrointestinal symptoms at presentation are associated with more severe COVID-19 illness in children.
- Underlying medical conditions increase the risk of severe COVID-19 outcomes in pediatric patients.
Abstract:
Purpose: Although less severe than in adults, children can experience a range of COVID-19 symptoms, from asymptomatic to life-threatening, including respiratory and gastrointestinal symptoms. Medical conditions may also increase the severity of the disease in infected children. Methods: This study was performed at a single center, comparing cases and controls, and involving 253 pediatric patients who had been diagnosed with COVID-19. Two different outcomes were assessed. The first categorized symptomatic individuals who were hospitalized with COVID-19 (hospital) from those who were not (nonhospital). The second categorized admitted individuals who spent at least one day in the intensive care unit (ICU) from those who did not require intensive care (floor). Results: Ninety individuals (36%) had at least one underlying medical condition, the most common being pulmonary disorders, such as asthma (12%), followed by neurodevelopmental disorders (8%), gastrointestinal disorders (6%), and seizure disorders (6%). The hospital group was more likely to have a comorbidity, such as obstructive sleep apnea (OSA), diabetes mellitus, seizure disorder, hypertension, sickle cell disease, neurodevelopmental disorder, and immunocompromising conditions, including cancer, bone marrow transplant, and other immunodeficiencies, compared to the non-hospital group. Abdominal pain was more common in the hospital group. Shortness of breath (SOB) and diarrhea were significantly more common in the ICU group than in the floor group. Conclusions: Early identification of pediatric patients with severe COVID-19 is important to improve outcomes. In our single-center case-control study, we found that the presence of gastrointestinal symptoms on presentation was more commonly associated with severe COVID-19 in children.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
08:32Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Other Disorders of Digestive System
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Gastrointestinal Motility Disorders
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...